The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroids.

Bäckström T, Turkmen S, Das R, Doverskog M, Blackburn TP.

DOI: 10.1111/joim.13705
Published: 2023-07-30
Container: J Intern Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/joim.13705,
  title = {The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroids.},
  author = {Bäckström T and  Turkmen S and  Das R and  Doverskog M and  Blackburn TP.},
  year = {2023},
  journal = {J Intern Med},
  doi = {10.1111/joim.13705},
  url = {https://doi.org/10.1111/joim.13705}
}

RIS

TY  - JOUR
TI  - The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroids.
AU  - Bäckström T
AU  -  Turkmen S
AU  -  Das R
AU  -  Doverskog M
AU  -  Blackburn TP.
PY  - 2023
JO  - J Intern Med
DO  - 10.1111/joim.13705
UR  - https://doi.org/10.1111/joim.13705
ER  -

APA

T, B., S, T., R, D., M, D., & TP., B. (2023). The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroids.. J Intern Med. https://doi.org/10.1111/joim.13705

Source records

europe-pmc · retrieved 2026-09-27T02:38:21.294Z